ATE224442T1 - Zielgerichtetes einbringen eines virus-vektors in säugetierzellen. - Google Patents
Zielgerichtetes einbringen eines virus-vektors in säugetierzellen.Info
- Publication number
- ATE224442T1 ATE224442T1 AT92922980T AT92922980T ATE224442T1 AT E224442 T1 ATE224442 T1 AT E224442T1 AT 92922980 T AT92922980 T AT 92922980T AT 92922980 T AT92922980 T AT 92922980T AT E224442 T1 ATE224442 T1 AT E224442T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- virus
- virus vector
- mammal cells
- targeted introduction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9103183A SE503225C2 (sv) | 1991-10-30 | 1991-10-30 | Virus-antikroppskomplex för införing av virus i mammalieceller |
PCT/SE1992/000745 WO1993009221A1 (en) | 1991-10-30 | 1992-10-28 | Targeted delivery of virus vector to mammalian cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE224442T1 true ATE224442T1 (de) | 2002-10-15 |
Family
ID=20384166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92922980T ATE224442T1 (de) | 1991-10-30 | 1992-10-28 | Zielgerichtetes einbringen eines virus-vektors in säugetierzellen. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5695991A (de) |
EP (1) | EP0614486B1 (de) |
JP (1) | JPH07502026A (de) |
AT (1) | ATE224442T1 (de) |
CA (1) | CA2122613C (de) |
DE (1) | DE69232782T2 (de) |
ES (1) | ES2180538T3 (de) |
SE (1) | SE503225C2 (de) |
WO (1) | WO1993009221A1 (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE503225C2 (sv) * | 1991-10-30 | 1996-04-22 | Leif Lindholm Konsult Ab | Virus-antikroppskomplex för införing av virus i mammalieceller |
GB9223084D0 (en) * | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
DE4311651A1 (de) * | 1993-04-08 | 1994-10-13 | Boehringer Ingelheim Int | Virus für den Transport von Fremd-DNA in höhere eukaryotische Zellen |
US5846782A (en) * | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
US6465253B1 (en) | 1994-09-08 | 2002-10-15 | Genvec, Inc. | Vectors and methods for gene transfer to cells |
US5753499A (en) * | 1994-12-23 | 1998-05-19 | New York University | Viral vector complexes having adapters of predefined valence |
US6127525A (en) * | 1995-02-21 | 2000-10-03 | Cornell Research Foundation, Inc. | Chimeric adenoviral coat protein and methods of using same |
US5770442A (en) | 1995-02-21 | 1998-06-23 | Cornell Research Foundation, Inc. | Chimeric adenoviral fiber protein and methods of using same |
US6261554B1 (en) | 1995-07-25 | 2001-07-17 | Introgene B.V. | Compositions for targeted gene delivery |
EA003195B1 (ru) * | 1995-11-13 | 2003-02-27 | Такара Сузо Ко., Лтд. | Способ повышения эффективности генного переноса в клетки-мишени с помощью ретровируса |
DE19605279A1 (de) | 1996-02-13 | 1997-08-14 | Hoechst Ag | Zielzellspezifische Vektoren für die Einschleusung von Genen in Zellen, Arzneimittel enthaltend derartige Vektoren und deren Verwendung |
CA2251738A1 (en) * | 1996-04-16 | 1997-10-23 | Immusol Incorporated | Targeted viral vectors |
US20060002949A1 (en) | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
US6797276B1 (en) | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
DE19649645A1 (de) * | 1996-11-29 | 1998-06-04 | Hoechst Ag | Mehrfach funktionelles Ligandensystem zur zielzellspezifischen Übertragung von Nukleotidsequenzen |
US6432699B1 (en) | 1997-03-28 | 2002-08-13 | New York University | Viral vectors having chimeric envelope proteins containing the IgG-binding domain of protein A |
CA2285937C (en) | 1997-04-10 | 2010-12-14 | Frederick L. Hall | Modified proteins which bind extracellular matrix components |
AU7127798A (en) * | 1997-04-18 | 1998-11-13 | President And Fellows Of Harvard College | Bifunctional polypeptides for cell-specific viral targeting |
US6004798A (en) * | 1997-05-14 | 1999-12-21 | University Of Southern California | Retroviral envelopes having modified hypervariable polyproline regions |
CA2318981A1 (en) * | 1998-02-09 | 1999-08-12 | Genzyme Corporation | Nucleic acid delivery vehicles |
US6287857B1 (en) | 1998-02-09 | 2001-09-11 | Genzyme Corporation | Nucleic acid delivery vehicles |
US20060292121A1 (en) * | 1998-04-29 | 2006-12-28 | Hall Frederick L | Retroviral vectors including modified envelope escort protein |
US7078483B2 (en) | 1998-04-29 | 2006-07-18 | University Of Southern California | Retroviral vectors including modified envelope escort proteins |
AU4070499A (en) | 1998-04-30 | 1999-11-16 | Cornell Research Foundation Inc. | Adenoviral vectors with tandem fiber proteins |
US6060316A (en) * | 1998-06-09 | 2000-05-09 | President And Fellows Of Harvard College | Methods of targeting of viral entry |
US6455314B1 (en) | 1998-09-11 | 2002-09-24 | Genvec, Inc. | Alternatively targeted adenovirus |
AUPQ425699A0 (en) | 1999-11-25 | 1999-12-23 | University Of Newcastle Research Associates Limited, The | A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
JP2003534806A (ja) * | 2000-05-31 | 2003-11-25 | ジェンベク、インコーポレイティッド | アデノウイルスベクターのターゲティングの方法および組成物 |
AU2002953436A0 (en) | 2002-12-18 | 2003-01-09 | The University Of Newcastle Research Associates Limited | A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
US11266736B2 (en) | 2008-04-17 | 2022-03-08 | Vin De Bona Trading Company Pte Ltd | Method of painting micro vesicles |
EP2281033B1 (de) | 2008-04-17 | 2014-10-15 | Vin de Bona Trading Co Pte | Modifizierung viraler hüllen nach deren freisetzung |
CN110418650A (zh) | 2016-11-16 | 2019-11-05 | 免疫治疗有限公司 | 用于治疗过敏的核酸 |
EP3612556A1 (de) | 2017-04-22 | 2020-02-26 | Immunomic Therapeutics, Inc. | Verbesserte lampenkonstruktionen |
US20200087365A1 (en) | 2017-05-02 | 2020-03-19 | Immunomic Therapeutics, Inc | Improved lamp constructs comprising cancer antigens |
US20210261647A1 (en) | 2018-05-15 | 2021-08-26 | Immunomic Therapeutics, Inc | Lamp constructs comprising allergens |
US20240108703A1 (en) | 2019-10-18 | 2024-04-04 | Immunomic Therapeutics, Inc. | Improved LAMP Constructs Comprising Cancer Antigens |
WO2023201201A1 (en) | 2022-04-10 | 2023-10-19 | Immunomic Therapeutics, Inc. | Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4364934A (en) * | 1979-12-04 | 1982-12-21 | Ortho Pharmaceutical Corporation | Monoclonal antibody to a human early thymocyte antigen and methods for preparing same |
US5428132A (en) * | 1987-10-11 | 1995-06-27 | United States Of America | Conjugate and method for integration of foreign DNA into cells |
JP2917998B2 (ja) * | 1988-02-05 | 1999-07-12 | ホワイトヘッド・インスティチュート・フォー・バイオメディカル・リサーチ | 修飾された肝細胞およびその用途 |
EP0466815A4 (en) * | 1989-04-05 | 1992-09-02 | Novacell Corpporation | Infectious targetted replication-defective virion |
FR2649119A1 (fr) * | 1989-06-30 | 1991-01-04 | Centre Nat Rech Scient | Procede de pilotage de retrovirus en utilisant des complexes bifonctionnels |
EP1001032A3 (de) * | 1989-08-18 | 2005-02-23 | Chiron Corporation | Rekombinante Retroviren um Vektorkonstruktionen an Zielzellen zu liefern |
WO1991004753A1 (en) * | 1989-10-02 | 1991-04-18 | Cetus Corporation | Conjugates of antisense oligonucleotides and therapeutic uses thereof |
CA2092323A1 (en) * | 1990-10-01 | 1992-04-02 | George Y. Wu | Targeting viruses and cells for selective internalization by cells |
SE503225C2 (sv) * | 1991-10-30 | 1996-04-22 | Leif Lindholm Konsult Ab | Virus-antikroppskomplex för införing av virus i mammalieceller |
-
1991
- 1991-10-30 SE SE9103183A patent/SE503225C2/sv not_active IP Right Cessation
-
1992
- 1992-10-28 AT AT92922980T patent/ATE224442T1/de not_active IP Right Cessation
- 1992-10-28 US US08/232,028 patent/US5695991A/en not_active Expired - Fee Related
- 1992-10-28 CA CA002122613A patent/CA2122613C/en not_active Expired - Fee Related
- 1992-10-28 DE DE69232782T patent/DE69232782T2/de not_active Revoked
- 1992-10-28 EP EP92922980A patent/EP0614486B1/de not_active Revoked
- 1992-10-28 JP JP5508351A patent/JPH07502026A/ja not_active Ceased
- 1992-10-28 ES ES92922980T patent/ES2180538T3/es not_active Expired - Lifetime
- 1992-10-28 WO PCT/SE1992/000745 patent/WO1993009221A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SE503225C2 (sv) | 1996-04-22 |
JPH07502026A (ja) | 1995-03-02 |
WO1993009221A1 (en) | 1993-05-13 |
DE69232782D1 (de) | 2002-10-24 |
SE9103183L (sv) | 1993-05-01 |
EP0614486B1 (de) | 2002-09-18 |
US5695991A (en) | 1997-12-09 |
SE9103183D0 (sv) | 1991-10-30 |
EP0614486A1 (de) | 1994-09-14 |
CA2122613C (en) | 2003-08-19 |
DE69232782T2 (de) | 2003-02-20 |
CA2122613A1 (en) | 1993-05-13 |
ES2180538T3 (es) | 2003-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE224442T1 (de) | Zielgerichtetes einbringen eines virus-vektors in säugetierzellen. | |
MY104946A (en) | Antigen antibody conjugate. | |
CA2337494A1 (en) | Herpes virus vectors for dendritic cells | |
IL114444A (en) | Kit for inducing immune response against a tumor or a disease caused by an infectious agent | |
ES2161875T3 (es) | Celulas con multiples epitopos alterados en un antigeno superficial para uso en transplantes. | |
DK0807178T3 (da) | Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose | |
PT649537E (pt) | Imunoanalises para anticorpos anti-vhc utilizando antigenios com epitopos conformacionais | |
FI932912A (fi) | Testmetod och reagensfoerpackning avsedd foer den | |
DE69021953D1 (de) | Enzymimmuntest für Antigene und dafür verwendbare feste Phase. | |
DE3378611D1 (en) | Vaccine against dna viruses | |
SE9102014D0 (sv) | Foerfarande i samband med mammalieceller | |
DE29705307U1 (de) | Mehrzweck-Trägergerät | |
PT650523E (pt) | Antigene cdw52 recombinante | |
Deans | Molecular and functional analysis of CD45 in T cell development | |
London | Studies of the observed and theoretical variations of atmospheric ozone(Final Report, 1 Jan. 1977- 30 Jun. 1990) | |
IT1264078B1 (it) | Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus | |
IT9006602A1 (it) | Test immunoenzimatico per la ricerca e determinazione degli anticorpi anti-ss-dna. | |
ATE95312T1 (de) | Waschzusammensetzung, testsatz und ihre verwendung zur bestimmung eines viralen antigens aus herpes simplex. | |
CS298787A3 (en) | Micro-titrimetric plate for enzymoimmunological test for the detection of antibodies against nuclear antigen of epstain and barrow virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |